News About Capital Goods

Filters
  • Region:

    Japan, Germany

  • Sector:

    Capital Goods

  • Deal Size:

    $227 million
  • Buy Side Company:

    Nidec Corporation
  • Sell Side Company:

    Secop GmbH
  • Target Company:

Liberty Hall acquires Quatro

  • Region:

    Germany

  • Sector:

    Capital Goods

  • Deal Size:

    $1.2 billion
  • Buy Side Company:

    Standard Industries
  • Sell Side Company:

    Braas Monier Building Group S.A.
  • Target Company:

  • Region:

    Germany

  • Sector:

    Energy, Capital Goods

  • Deal Size:

    $210 million
  • Buy Side Company:

    CIRCOR International Inc
  • Sell Side Company:

    Sun Capital Partners
  • Target Company:

    Critical Flow Solutions

  • Region:

    India

  • Sector:

    Capital Goods

  • Deal Size:

    $18 million
  • Buy Side Company:

    Manali Petrochemicals
  • Sell Side Company:

    Notedome Ltd
  • Target Company:

  • Region:

    France

  • Sector:

    Capital Goods

  • Deal Size:

  • Buy Side Company:

    Elais Capital
  • Sell Side Company:

    Sunaero
  • Target Company:

  • Region:

    India

  • Sector:

    Capital Goods

  • Deal Size:

    $44.4 million
  • Buy Side Company:

    Suprajit Engineering Ltd
  • Sell Side Company:

    Wescon Controls
  • Target Company:

  • Region:

    Brazil

  • Sector:

    Capital Goods

  • Deal Size:

  • Buy Side Company:

  • Sell Side Company:

    Advent International Corporation
  • Target Company:

    TCP Terminal de Conteineres de Paranagua SA

  • Region:

    India

  • Sector:

    Materials, Capital Goods

  • Deal Size:

    $401m
  • Buy Side Company:

    Yara Fertilisers India Pvt Ltd
  • Sell Side Company:

    Tata Group
  • Target Company:

    Tata Chemicals

  • Region:

    Paris, Indonesia

  • Sector:

    Capital Goods

  • Deal Size:

  • Buy Side Company:

    Pertamina
  • Sell Side Company:

    Maurel & Prom
  • Target Company:

  • Region:

    India

  • Sector:

    Consumer Services, Capital Goods

  • Deal Size:

    $1.4 billion
  • Buy Side Company:

    Shanghai Fosun Pharmaceutical Group Co Ltd
  • Sell Side Company:

    Gland Pharma Limited
  • Target Company: